Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Organon Reports Results for the Second Quarter Ended June 30, 2025
07:30am, Tuesday, 05'th Aug 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon shares results for second quarter ended June 30, 2025.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Monday, 04'th Aug 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics
10:16am, Friday, 01'st Aug 2025
Get a deeper insight into the potential performance of Organon (OGN) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of
Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:50pm, Thursday, 31'st Jul 2025
In the most recent trading session, Organon (OGN) closed at $9.7, indicating a -3.39% shift from the previous trading day.
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Tuesday, 29'th Jul 2025
Organon (OGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organon (OGN) Outperforms Broader Market: What You Need to Know
06:51pm, Friday, 25'th Jul 2025
In the latest trading session, Organon (OGN) closed at $10.21, marking a +1.39% move from the previous day.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
10:01am, Wednesday, 23'rd Jul 2025
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Investors can contact the law firm at no cost to learn more about recovering their losses
Contact Levi & Korsinsky by July 22, 2025 Deadline to Join Class Action Against Organon & Co.(OGN)
03:34pm, Tuesday, 22'nd Jul 2025
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.
NEW YORK , July 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advi
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
09:47am, Tuesday, 22'nd Jul 2025
NEW YORK--(BUSINESS WIRE)---- $OGN #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Organon & Co. (“Organon” or the “Company�
NEW YORK , July 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Organon (OGN) To Contact Him Directly To Discuss Their Options If you purchased or acquire
Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025
07:30am, Tuesday, 22'nd Jul 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon to report second quarter 2025 results and host conference call on August 5, 2025.
The Gross Law Firm Notifies Organon & Co. Investors of a Class Action Lawsuit and Upcoming Deadline – OGN
04:32pm, Monday, 21'st Jul 2025
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).
